PUBLIC

NEWS

Signed Joint R&D Agreement with ToolGen

2022-12-20


 

▲ Kim Young-ho, CEO of ToolGen (left), and Moon Hong-sung, CEO of GENIXCURE



View the original article




Prev
Strategic Alliance with MedySapiens for Rare Disease Programs
Next
GXC-301 presented by Christopher Lim at '2023 Lafora Disease Science Symposium...
List